Intravenous contrast-induced nephropathy (CIN) is associated with significant in-hospital
morbidity. Numerous studies examining various contrast agents and the risks of CIN have …

Contrast-induced nephropathy (CIN) is a well-known complication of therapeutic and
diagnostic procedures requiring contrast administration and accounts for 10 to 12% of acute …

Contrast‐induced nephropathy (CIN) is an acute and severe complication after contrast
media administration. The most important step in preventing CIN is identifying high‐risk …

Contrast-induced nephropathy (CIN) is one of the most serious adverse events associated
with the use of contrast media (CM). Patients who develop this complication can have …

Contrast induced nephropathy (CIN) is a common cause of hospital acquired acute kidney
injury (AKI) and associated with adverse clinical outcomes. There is still debate regarding …

Contrast-induced nephropathy (CIN) is the third most common reason for hospital-acquired
acute kidney injury. In-hospital and long-term mortality and morbidity (eg, stroke, myocardial …

Contrast-induced nephropathy (CIN) has been considered to be a cause of renal failure for
over 50 years, but careful review of past and recent studies reveals the risks of CIN to be …

Contrast-induced nephropathy (CIN) is a serious, but potentially preventable adverse event
associated with the use of iodinated contrast media (CM). Studies suggest that the …

Radiological procedures utilizing intravenous iodinated contrast agents are being widely
utilized for both therapeutic and diagnostic purposes. This has resulted in an increasing …

With the advances made in radiology and cardiology, greater numbers of patients are
expected to undergo exposure to iodinated contrast media in the years to come. Contrast …